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Timed Average Mean Maximum Velocity (TAMMV) 
of Cerebral Blood Flow of Children and Adolescents 
with Sickle cell Disease: correlation with clinical and 




Detection of  abnormal TAMMV with transcranial Doppler is fundamental in primary stroke prevention in children with sickle cell 
disease (SCD). The study aimed at evaluating TAMMV and correlating it with clinical and hematological profiles of  children and 
adolescent with SCD. 
Methods 
Transcranial Doppler was performed on subjects aged 2-16 years, using a 2 MHz probe placed over the transtemporal windows. Pulse 
oximetry was used to determine the peripheral oxygen saturation while clinical and hematological profiles were retrieved from their 
medical records.
Results 
One hundred and thirty five patients were recruited. The mean TAMMV was 125cm/s. Patients with HbSS had a significantly higher 
TAMMV (131cm/s) than those with HbSC (107cm/s). Only one (0.74%) patient had abnormal TAMMV. TAMMV correlated 
inversely with oxygen saturation, Hct and patient’s age, and positively with white cell and platelet counts. Previous history of  acute 
chest syndrome (ACS) and recurrent painful crises increased the risk of  development of  abnormal and conditional velocity.
Conclusion 
Frequency of  abnormal TAMMV in this study was low. Younger children and those with HbSS had higher TAMMV. Age, oxygen 
saturation and haematocrit correlated negatively while white cell and platelet counts correlated positively with TAMMV. Previous 
history of  ACS and recurrent bone pain were associated with increased risk of  having abnormal and conditional TAMMV.
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Introduction
Sickle cell disease (SCD) is the commonest genetic disorder 
worldwide. In Brazil, the frequency of  sickle cell trait (SCT, 
HbAS) and prevalence of  SCD range from 1.1% to 9.8% 
and 0.8 to 60 per 100,000 births respectively. It is estimated 
that about 700-1000 children are born annually in Brazil 
with SCD1,2,3,4. Salvador, Bahia, has the highest burden of  
both the trait and the disease, with frequency of  SCT and 
prevalence of  SCD being 9.8% and 0.17% respectively5,6.
Cerebrovascular accident (CVA) or stroke is a devastating 
complication of  SCD and up to 11% of  children with 
HbSS genotype are at risk of  developing stroke before the 
age of  20 years, with highest incidence occurring between 
2-5 years7. The incidence of  stroke among Brazilian 
children with SCD ranged from 17.2-27.3%8. Proliferative 
vasculopathy of  large intracranial internal carotid arteries 
and their proximal branches is the pathophysiological basis 
for development of  ischemic stroke in SCD, although 
micro-infarcts in the deep white matter and diffuse arteriolar 
thickening have been reported in some neuropathological 
studies with normal cerebral angiograms in cases of  acute 
clinical stroke9,10,11 Risk factors for occurrence of  stroke in 
SCD include anemia, leukocytosis, thrombocytosis, previous 
stroke, silent cerebral infarction, and systemic hypertension 
with abnormal TAMMV as the most important risk factor7,12. 
Detection of  abnormal TAMMV with transcranial Doppler 
(TCD) and prophylactic blood transfusion are fundamental 
to primary stroke prevention in SCD13.  
Apart from TCD, are there other parameters that may 
indicate an increased TAMMV in children with SCD? 
Previous studies on TCD in Brazilian children were mainly 
on relationship between TAMMV and haemoglobin 
concentration14,15 and there is paucity of  data on TAMMV 
and its relationship with other haematological parameters. 
The aim of  the present study was to evaluate TAMMV 
of  children and adolescents with SCD, detect those with 
conditional and abnormal TAMMV and correlate TAMMV 
with hematological (haematocrit, WBC, platelets) and clinical 
profiles of  the patients.
Materials and Methods
This cross sectional study was conducted at the Pediatric 
Hematology outpatient clinic of  Professor Edgard Santos 
University Hospital, Salvador, Brazil, between March 2016 
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and Feb. 2017. Patients included in the study were aged 
2-16 years, confirmed to have SCD, in a steady state while 
patients with past history of  stroke or on prophylactic 
blood transfusion or had received blood transfusion for any 
other reason within the preceding 3 months were excluded. 
Patients in steady state were regarded as those that did not 
present with any acute illness necessitating emergency visit 
or hospital admission in the past four weeks and did not 
have recurrent infection or inflammation within the past 
four weeks before TCD evaluation16. All the patients who 
presented to the clinic over the study period and met the 
inclusion criteria were recruited consecutively for TCD 
evaluation.  Clinical risk factors of  stroke including past 
history of  stroke, ACS or pneumonia, recurrent bone pain 
and priapism within the preceding twelve months were 
obtained from patients or caregivers and verified from the 
patients’ medical records. Recurrent bone pain crisis was 
regarded as three or more painful episodes that required visit 
to the emergency room or hospital admission within the past 
12 months. The steady state hematological parameters and 
use of  hydroxyurea (HU) were also obtained from patients’ 
medical records. The steady state hematological parameters 
were taken as values obtained within the preceding 3 months 
without blood transfusion; and included, hemoglobin 
concentration, hematocrit, reticulocyte, WBC, neutrophil, 
monocyte, and platelet counts. It was ensured that patients 
on HU had been on stable dose for at least six months before 
TCD evaluation.
The arterial oxygen saturation (SpO2) was determined with 
pulse oximeter (Geratherm Medical, Germany) placed 
on the right index finger of  the patient at the time of  
TCD. Conventional TCD screening as recommended by 
Stroke prevention trial in SCA (STOP) and the Brazilian 
guidelines for TCD in children and adolescents with SCD 
was performed, using a single non-imaging device Doppler 
probe (2MHZ) transducer (Sonatek, Viasys Healthcare and 
Cardinal Health, USA) on the trans-temporal windows.17,18 
The indications, procedures, advantages and risks of  the 
examination were explained to the patients and/or caregivers 
before the examination. 
The examination was done while patient was in supine 
position, awake, calm, and alert but not allowed to sleep 
because increase in CO2 during sleep can increase TAMMV. 
It was also ensured that patient was not febrile, agitated 
or crying during examination as these may falsely increase 
TAMMV. While patient was lying supine and looking contra 
laterally, the examiner sat at the head of  the bed with easy 
access to the instruments. The lubricated 2MHz frequency 
TCD probe was placed over the transtemporal window 
to insonate the basal cerebral arteries. The arteries were 
identified based on relative direction of  the probe within 
the acoustic window, direction of  blood flow relative to the 
probe, and depth of  insonation. The distal internal carotid 
artery (ICA) or its bifurcation was identified at depths of  
55 to 65mm with simultaneous flow away and towards the 
probe. The middle cerebral artery (MCA) was identified at 
depths of  35 to 55mm with blood flow towards the probe 
while the anterior cerebral artery (ACA) was viewed at depths 
of  60 to 70mm with blood flow away from the probe.  Both 
audible and visual signals of  the Doppler wave form were 
assessed with the aim of  recognizing turbulence and other 
audible clues that suggest high velocities; and with the goal of  
obtaining the “cleanest,” sharpest and highest velocity signal. 
The timed average mean maximum velocities (TAMMV) in 
the proximal MCA and distal ICA were recorded from both 
hemispheres according to the STOP protocol for SCD17.   
Written informed consent was obtained from caregivers 
and ascent from children of  seven years and above. Ethical 
approval was obtained from the Institutional Review Board 
before commencing the study (IR 314.636).
The data were analyzed with statistical software (STATA 10, 
College Station, Tex: Stata Corp) and (SPSS 20.0, Armonk, 
NY: IBM Corp).  Interval variables were presented as 
means and standard deviations for parametric variables or 
median and range for non-parametric variables.  Categorical 
variables were presented in form of  tables, proportions 
and percentages. Test of  significance was assessed using 
Student’s-T test for parametric interval variables and Mann 
Whitney test for non-parametric variables. Chi-square test or 
Fischer’s exact test was used to test for significant difference 
between categorical variables. Correlations were assessed 
using Spearman’s correlation coefficients.  Eta coefficient 
was used to determine the strength of  association between 
categorical independent variable (class of  TAMMV) and 
interval dependent variables. Linear regression analysis was 
used to establish associations between dependent (TAMMV) 
and independent variables (age, SpO2, haematocrit, WBC, 
platelets, reticulocytes) after log transformation of  the data. 
Odds of  having abnormal or conditional TCD result were 
calculated for those that had history of  clinical risk factors 
under study. Test of  significance was set at p <0.05. 
Results
Patients’ Characteristics
The subjects comprised 74 (54.8%) females and 61 (45.2%) 
males with median age of  8 years (2-16). Ninety three 
(68.9%) of  them had HbSS genotype, 41 (30.4%) HbSC and 
one (0.7%), Sβ+ thalassemia genotype. Fifty one (37.8%) 
of  the patients were taking HU as at the period of  TCD 
screening for various indications, such as recurrent bone 
pain, past history of  acute chest syndrome, or previous 
abnormal TCD report. The median weight, height and body 
mass index (BMI) of  the patients were 23.6 (11-75.2) kg, 1.3 
(0.8-1.8) M and 16.3 (10.7- 27.3) Kg/M2 respectively. 
Transcranial Doppler screening
The median of  the TAMMV was 125 cm/s (74.4-202). One 
patient (0.74%) had abnormal result (≥200cm/s) while 18 
(13.33%) had conditional TAMMV (170-199cm/s). None 
had low TCD result (< 70cm/s).
The females had a median TAMMV of  125.5 (74.7-199) 
cm/s in comparison with the males’ 122 (74.4-202) cm/s, 
with no significant difference (Mann-Whitney test, p = 0.5). 
One (1.6%) of  the males had abnormal result, 8 (13.1%) had 
conditional results while 10 (13.5%) of  the females also had 
conditional results, with no significant difference (Fischer’s 
exact, p = 0.7). 
The age group, 6-9 years had the highest median TAMMV 
of  131cm/s while those aged 14-16 years had the lowest 
velocity of  111cm/s (Kruskal-Wallis test, p = 0.01) as shown 
in table 1. While the only abnormal TCD result was recorded 
in the age group 2-5 years, 88.9% (16/18) of  the conditional 
results was in the under 10. 
TAMMV did not differ significantly (Wilcoxon signed-rank 
test: z= -0.9, p=   0.4) between the right (118cm/s) and left 
(120cm/s) middle cerebral arteries, nor among patients on 
(128cm/s) or not on (121cm/s) HU therapy (Mann-Whitney 
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Table 1: TCD results based on patients’age.
Age category 
(years)
TCD        result
 
N (%) Median (cm/s) Normal (%) Conditional (%) Abnormal (%)
  2-5            41 (30.4)   127.0         32 (23.7)         8 (5.9)               1(0.7)
  6-9            43 (31.8)    131               35 (25.9)     8 (5.9)               0 (0)
 10-13        36 (26.7)     121.5           26 (19.3)       (0.7)               0 (0)
 14-16       15 (11.1)      111              23 (17.0)       1 (0.7)              0 (0)
                
P = 0.01
Table 2: Hematological variables and SpO2 based on TCD result.
TCD Hct (%) Hb (g/dl) SpO2 (%) WBC (/L) ANC (/L) AMC (/L) Platelets (/L) Retics (%) HbF (%)
Normal     27.4 9.2             97         9200 5388 727       369,148       3.6      9.2
Conditional  23.2     7.8      94         14250            8216 1388       538,300          8.3     6.3
Abnormal  21 6.9                92         12300             6396 1250       529,000        4.4     3.2
P value     0.008     0.005             0.0002         0.01              0.004 0.0001        0.0003          0.1     0.05
Values indicated in the table were median values, except hemoglobin which was as mean value. Hct, Hematocrit; 
Hb, Hemoglobin; Retics, Reticulocyte count; HbF, Fetal hemoglobin; ANC, Absolute neutrophil count; AMC, 
Absolute monocyte count. 
test: p= 0.4).
Comparing TAMMV among the two major genotypes, it 
was observed that patients with HbSS had higher median 
TAMMV (131cm/s) compared to those with HbSC 
(107cm/s), with a statistically significant difference (Mann-
Whitney test, p<0.0001). Only the HbSS patients had 
abnormal or conditional velocity (OR = 10.8, 95% CI = 
1.58-485.5, p = 0.005).
The study compared the hemoglobin oxygen saturation 
(SpO2) and hematological indices among the patients in 
relation to their TCD results (Table. 2). It was observed 
that patients with abnormal or conditional results had lower 
SpO2 (< 95%) compared to those with normal result with 
a statistically significant difference (Kruskal-Wallis test: p= 
0.0002). Patients with abnormal or conditional TCD results 
also had lower mean hemoglobin concentration compared 
with those with normal results. One-way analysis of  variance 
(ANOVA) indicated a statistically significant difference in 
the mean hemoglobin concentrations (ANOVA: F= 5.58, 
p= 0.005). 
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Table 3: Median haematological variables compared between patients on hydroxyurea and those not taking the drug
Variables Hydroxyurea  Median P value
Total WBC(μl)         Yes                           9600                       
                          No                           9700                         0.7
Hct (%)                    Yes                           27.3                         
                          No                            27.0                          0.9
ANC (μl)                  Yes                           4317                          
                                 No                           4816                          0.5
AMC (μl)                 Yes                           689                                                                        
                                 No                            765                            0.5
Platelets (μl)             Yes                         406000                       
                                 No                          389500                        0.7
Retics (%)                Yes                           4.7                                    
                                 No                            4.5                              0.9
ANC; absolute neutrophil count, AMC; absolute monocyte count, Retics; reticulocyte count
Table 4: Correlation between TAMMV and patients’ hematological indices and SpO2
Variable N Spearman ᵨ P value
Age                                 135   -2.0   0.02
SpO2      135   -0.35   0.0001
Hemoglobin      75   -0.50   0.0000
Hematocrit      75   -0.50   0.0000
Reticulocyte count      72    - 0.51   0.0000
HbF       72   0.03   0.8
Total WBC      75   0.34   0.003
Platelet count      75   0.34   0.003
ANC       75   0.30   0.01
AMC       75   0.53   0.0000
ANC, absolute neutrophil count; AMC, absolute monocyte count; HbF, fetal hemoglobin; 
TAMMV, Timed average mean maximum.
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Table 5: Association between class of TAMMV (normal, conditional, abnormal) and the independent variables
Eta coefficient
Nominal by Interval Eta









Absolute neutrophil count 0.310




0.2-0.39 indicate weak association, 0.4-0.69 indicates medium association, ≥0.7-1 indicates strong association
Table 6: Multiple linear regression analysis between TAMMV and its independent predictors.
Variables Coef. T P value 95% CI.
Age          -0.0006      3.2   0.002     0.0009-0.0002
SpO2         -0.0002     0.36   0.7     -0.007-001
Hb          -0.004     -1.8   0.08      -0.0005-0.0008
WBC           1.97     3.17    0.002       3.2-7.3
ANC           1.84     2.23   0.03       1.93-3.48
AMC           9.9     3.95   0.000        0.0002-4.9
Platelets           1.03     1.42           0.16        2.48-4.22
Retics           0.00035     1.54   0.13        0.0001-0.0008
HbF          -0.005    -2.79   0.007        0.0009-0.0001  
TAMMV= Timed average mean maximum velocity, ANC= Absolute neutrophil count, AMC= 
Absolute monocyte count, Retics= Reticulocyte count, HbF= fetal hemoglobin.
Percentage of  HbF was lower in patients with abnormal 
(3.3%) or conditional (6.3%) TCD results than those with 
normal (9.2%) results, but the difference was not significant 
(Kruskal-Wallis test: p= 0.05). Following a similar pattern, 
there was no significant difference (Kruskal-Wallis test: p= 
0.1) in the reticulocyte count among patients with normal 
(4.4%), conditional (8.3%) or abnormal (3.6%) TCD results. 
It was observed that patients with conditional or abnormal 
TCD results had higher white cell and platelet counts than 
those with normal results. Test of  significance (Kruskal-
Wallis test) also indicated that the differences in WBC and 
platelet counts were statistically significant. 
The haematological profiles of  patients on hydroxyurea 
were comparable with those not taking the drug as shown 
in table 3. Most of  the parameters were higher in children 
that were not on hydroxyurea, although the differences were 
not significant. The haematocrit was higher in children on 
hydroxyurea. 
As shown in table 4, Spearman’s correlation analysis indicated 
that patients’ age, SpO2, and hematocrit negatively correlated 
with TAMMV. Total leukocyte, neutrophil, monocyte, 
platelet, and reticulocyte counts had positive correlation 
with TAMMV. These findings demonstrate that increased 
TAMMV is associated with younger age, low SpO2, low 
hematocrit/hemoglobin and elevated leukocyte, neutrophil, 
monocyte, platelet, and reticulocyte counts.  There was no 
correlation between HbF concentration and TAMMV. 
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The strength of  association between the class of  TAMMV 
(normal, conditional, abnormal) and the dependent variables 
is as in table 5. While the strength of  association between 
class of  TAMMV and oxygen saturation, absolute monocyte 
count and platelet count was medium, that with age, 
haematocrit, fetal haemoglobin was a weak association.
After log transformation of  the non-parametric variables, a 
multiple linear regression model was used to assess for a linear 
relationship between TAMMV and the independent variables 
(age, SpO2, haematocrit, WBC, platelets, reticulocytes). 
This regression model showed that the independent 
variables statistically significantly predicted the dependent 
variable (TAMMV), F (10, 60) =8.87, p=0.0000), although 
responsible for only 60% of  the variability of  TAMMV 
(R2 = 0.5964).  Young age and low HbF had negative 
association with TAMMV while total leukocyte, neutrophil, 
and monocyte counts independently had positive association 
with TAMMV, when other variables were held constant (p= 
0.002, 0.002, 0.03, 0.000, and 0.007 respectively)-Table 6.
A risk analysis showed that patients who have had ACS in the 
preceding year were sixteen times at risk of  having abnormal 
or conditional TCD result compared to those without the 
complication. Out of  the 23 patients that suffered ACS, 
12 had altered TAMMV (Odds ratio= 16.4; X2 =33.3, p= 
0.000, 95% CI= 4.6-58.6). In the same vein, 17 of  66 that 
had recurrent painful crises had abnormal or conditional 
result (Odds ratio= 11.3, X2 = 14.1, p= 0.0002, 95% CI= 
2.4535-103.5636). No case of  priapism was recorded in the 
present study.
Discussion
Since the revelation from STOP clinical study with TCD 
in the late 1990s, the incidence of  stroke in children with 
SCD has markedly reduced, compared to the pre-TCD era13. 
TCD identifies those at high risk of  developing stroke and by 
instituting prophylactic blood transfusion program on them, 
stroke and other complications of  SCD are minimized13,19.        
In this study, the prevalence of  abnormal TCD result was 
comparable to 1.6% and 2.6 % reported by Hokazono et al 
and Melo et al., as well as that by Leite et al. in different parts 
of  Brazil14,20,21. However, it was lower than that reported 
in Nigeria (8.4%) by Lagunju et al and in Iraq (13.33%) by 
Hasan et al.22,23. The difference in prevalence could have 
resulted from use of  hydroxyurea in Brazilian children. 
Access and adherence rate of  hydroxyurea among sickle 
cell patients is high in Brazil24. The differences in prevalence 
could also be due to differences in the number of  patients 
screened or other factors including genetic. Genetic factors 
associated with increased risk of  stroke in SCD include the 
haplotype, co-inheritance of  alpha thalassemia, persistence 
of  HbF production as well as inheritance of  genes involved 
in inflammation, hypoxia, adherence molecules and 
coagulation25. 
There is tendency for conditional TCD to convert to 
abnormal result, which increases the risk of  stroke. It is 
therefore imperative that measures be put in place to avert this 
conversion26. Apart from 3-6 monthly monitoring of  TCD 
velocity in those with conditional results, no intervention 
measure is yet recommended, although some researchers 
have demonstrated the effectiveness of  HU in preventing 
conversion of  conditional to normal result, thereby reducing 
the risk of  stroke in children with SCD27.  
Patients with SCA had higher TAMMV compared to other 
genotypes. This was in agreement with report by Hokazono 
et al.14 In the present study, all the abnormal and conditional 
results were from patients with HbSS genotype. Vieira et al. 
observed also that patients with HbSS had significantly higher 
TAMMV compared to HbSC disease patients and suggested 
a lower cut-off  point for the latter patients15. HbSS genotype 
confers is a more severe type of  SCD compared to other 
genotypes28. Apart from higher prevalence of  abnormal 
or conditional TAMMV and higher risk of  CVA, patients 
with genotype HbSS have higher rates of  hemolysis, lower 
hemoglobin, SpO2, and cardiac and other complications 
when compared with other genotypes29. In a comparative 
study of  chronic kidney disease among SCD patients, it was 
observed that homozygous HbS patients were more severely 
affected than HbSC counterparts30. HbSS and HbSβ0 
-thalassemia generally present most severe clinical and 
hematological symptoms while HbSC and HbSβ+ -present 
less severe disease. 
This study also observed that the age group with the highest 
median of  TAMMV was 6-9 years. Thereafter, TAMMV 
decreased with increasing age. This trend was in agreement 
with report by Lagunju et al and Makani et al. among patients 
with HbSS genotype and conformed to the general pattern 
of  TAMMV in children without SCD.22,31 According to 
Schӧning et al., TAMMV increases markedly from 3 years 
of  age and peaks at about the age of  6 years, and gradually 
decreasing until 15 years when it reaches a constant value32. 
Brass et al. also observed that cerebral blood flow reaches 
maximum at about the 6th year of  life, with a direct 
relationship between it and blood flow velocity33. This study 
also established a significant inverse correlation between 
TAMMV and patient’s age. This trend, in combination with 
other factors such as genetic and environmental factors could 
be the reason why vasculopathy in SCD, abnormal TCD, 
and stroke are commoner in younger children with SCD. 
Other complications of  SCD commoner in the younger age 
group include ACS, splenic sequestration and parvovirus 
B19 infection with aplastic crisis. These complications 
have a common association with infection, either viral or 
bacterial34,35,36. Therefore, it may be conceivable to think that 
sickle cell vasculopathy is also related to infections among 
this age group. Further studies are required to prove or 
debunk this conception. 
It may be surprising to note that there was no significant 
difference in TAMMV between those taking HU and their 
counterparts who were not taking the medication. It is known 
that HU can reverse abnormal TAMMV to conditional 
or normal and it may be possible that the patients on HU 
previously had conditional or abnormal TAMMV that 
reversed on taking the drug. However, we did not document 
the specific indications for use of  HU among the individual 
patients.
A significant negative correlation was noted between 
TAMMV and SpO2, hemoglobin and hematocrit. This 
finding concurred with previous studies22,31,37. Blood 
desaturation impairs oxygen delivery to the cerebral tissue 
and predisposes to CVA. Patients with SCD have chronic 
anemia arising from chronic hemolysis and recurrent 
infections. In anemia and desaturation, the circulatory 
system responds by lowering peripheral resistance, increasing 
cardiac output, which increases cerebral blood flow through 
increase in blood flow velocity38. Increased blood flow 
triggers turbulent flow, predisposing to vascular endothelial 
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damage, inflammation, hyperplasia and hypertrophy of  
vascular smooth muscle, stenosis, cerebral ischemia, and 
increased risk stroke39. Maintaining a stable hemoglobin 
concentration at or close to 10g/dl by transfusions or drugs 
that increase the level of  HbF and hemoglobin such as 
HU reduces the risk of  abnormal TAMMV and stroke in 
children with SCD. Increased hemoglobin level improves 
oxygen transport and delivery to the brain, thereby reducing 
the risk of  stroke. Chronic transfusion increases the normal 
hemoglobin level, reduces hypoxia and percentage of  HbS 
(< 30%) and improves oxygen saturation and delivery to 
cerebral and other tissues.
The positive correlation between TAMMV and leukocyte, 
neutrophil and monocyte counts, platelet count and 
reticulocyte was also observed by Ismail et al in Kano, Nigeria40, 
Adekunle et al41 in Lagos, Nigeria also observed a significant 
correlation between TAMMV and leukocytosis and this could 
be ascribed to the fact that these cells are active participants 
in the chronic inflammatory process in SCD. Other studies 
have also shown higher counts and activation of  these cells in 
patients with SCD, and more so in those with complications 
of  the disease21,42. Reticulocyte count is an indirect marker 
of  intravascular hemolysis, a major pathological process in 
SCD in which free hemoglobin and heme are released into 
the circulation, with consequent scavenging of  nitric oxide, 
endothelial injury, elaboration of  proinflammatory cytokines 
and cellular adhesion molecules. The WBC in the multiple 
linear regression model independently predicted cerebral 
blood flow velocity, a major risk factor in development of  
CVA in children with SCD.  Study by Conran and colleagues 
observed that severity of  SCD is associated with increased 
WBC count while a reduction ameliorates the severity of  
the disease7,43. The platelet count, absolute monocyte count 
and oxygen saturation had medium strength of  association 
with the class of  TAMMV as these are important risk factors 
for development of  conditional or abnormal TAMMV and 
stroke in sickle cell disease.
In the multiple linear regression model, patient’s age, total 
WBC, absolute neutrophil and monocyte counts, and HbF, 
were independently associated with cerebral blood flow 
velocity. Studies by Quinn et al observed inverse relationship 
between TAMMV and SpO2 and hematocrit
37. Also in the 
multivariate model by Makani et al, it was observed that 
low SPO2 ≤ 95%, young age and a history of  fever were 
associated with high cerebral blood flow velocity31. There 
is a dearth of  information on a direct relationship between 
TAMMV and WBC, although Colombatti et al recently 
report an association between it and increased leukocyte 
count44. The final consequence of  cerebral vasculopathy 
in SCD is vascular stenosis, which results from vascular 
smooth muscle remodeling, hyperplasia and hypertrophy. 
All these result from chronic inflammation, which is 
directly or indirectly triggered by hemolysis, adherence of  
sickle red cells and other cells to vascular endothelium, 
elaboration of  proinflammatory cytokines and activation of  
proinflammatory cells45.
Children who had suffered ACS/pneumonia or recurrent 
painful crises had higher probability of  having an abnormal 
or conditional cerebral blood flow velocity. ACS is an acute 
illness characterized by fever, acute respiratory symptoms, 
new pulmonary infiltrates on chest X-ray and hypoxia. 
This complication may result from pulmonary infection 
(pneumonia) or fat embolism from necrotic bone infarction, 
resulting in fall in pulmonary oxygen tension, oxygen 
desaturation, sickle hemoglobin polymerization, red blood 
cell sickling leading to hemolysis and inflammation35. ACS 
is a known risk factor of  stroke and other encephalopathies 
in patients with SCA7,46. Pulmonary hypoxia from ACS 
can predispose to reduction in delivery of  oxygenated 
blood to cerebral tissues with resultant cerebral vascular 
endothelial injury, cerebral arterial smooth muscle modeling, 
stenosis with cerebral ischemia and stroke.  Recurrent vaso-
occlusion and pain with subsequent reperfusion injury, 
endothelial activation, inflammation and vascular smooth 
muscle hyperplasia and hypertrophy predisposes to cerebral 
vessel stenosis and increased risk of  elevated TAMMV and 
ischemic stroke in sickle cell disease.
Conclusion
The frequency of  abnormal TCD result was low in children 
with SCD in Salvador. Children with HbSS and those with 
past history of  acute chest syndrome or recurrent vaso-
occlusive episodes are more likely to have abnormal result 
while TAMMV correlated negatively with hematocrit, 
peripheral oxygen saturation and age, and positively with 
white cell and platelet counts. In facilities where universal 
TCD screening is not possible, priority may be given to 
those with HbSS, low oxygen saturation, past history of  
ACS, recurrent painful crisis or abnormally high leukocyte 
and platelet counts.
The study was limited by a few number of  patients with 
abnormal or conditional TCD results, making it difficult 
to have a statistically reliable conclusion. The retrieval of  
haematological profile of  the patients from the medical 
records was also a limitation as the values may not represent 
the true values as at time of  TCD. There was also no 
documentation of  the specific indications for use of  HU 
among individual patients on the medication. Further studies 
with more patients and documentation of  blood cellular 
values at time of  TCD are required.
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